| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 10/11/2012 | US20120260371 Polypeptides Having Cellobiohydrolase Activity and Polynucleotides Encoding Same | 
| 10/11/2012 | US20120259095 Monoclonal antibodies with enhanced adcc function | 
| 10/11/2012 | US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals | 
| 10/11/2012 | US20120258498 High yield antibiotics producing fungus strain, preparation method and use thereof | 
| 10/11/2012 | US20120258497 Alpha-Amylases | 
| 10/11/2012 | US20120258496 Production of low fucose antibodies in h4-ii-e rat cells | 
| 10/11/2012 | US20120258495 Sequence diversity generation in immunoglobulins | 
| 10/11/2012 | US20120258494 Retroviral Vector Particles and Methods for their Generation and Use | 
| 10/11/2012 | US20120258493 Promoter sequences | 
| 10/11/2012 | US20120258492 Bacterial host strain | 
| 10/11/2012 | US20120258491 Expression of biologically active polypeptides in duckweed | 
| 10/11/2012 | US20120258490 Process for producing dipeptides or dipeptide derivatives | 
| 10/11/2012 | US20120258489 Fungal promoters for expressing a gene in a fungal cell | 
| 10/11/2012 | US20120258465 Mutant apoprotein of photoprotein with low calcium sensitivity | 
| 10/11/2012 | US20120258458 Interferon-like protein zcyto21 | 
| 10/11/2012 | US20120258133 Construct | 
| 10/11/2012 | US20120258129 Mycobacterium tuberculosis fusion protein and uses thereof | 
| 10/11/2012 | US20120258122 Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 and Uses Thereof | 
| 10/11/2012 | US20120258114 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha | 
| 10/11/2012 | US20120258112 Antibodies against human ccn1 and uses thereof | 
| 10/11/2012 | US20120258108 Dual Variable Domain Immunoglobulins and Uses Thereof | 
| 10/11/2012 | US20120258096 Anti-d monoclonal antibodies | 
| 10/11/2012 | US20120258082 Production of ifn-lambda by conventional dendritic cells and uses thereof | 
| 10/11/2012 | US20120258072 Interleukin-11 Fusion Proteins | 
| 10/11/2012 | US20120258041 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition | 
| 10/11/2012 | CA2832106A1 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition | 
| 10/11/2012 | CA2831751A1 Novel anti-human il-23 receptor antibody | 
| 10/11/2012 | CA2830183A1 Extraction of proteins from algae | 
| 10/11/2012 | CA2830013A1 Recombinant polypeptide production method | 
| 10/10/2012 | EP2508614A2 Glycosylation of molecules | 
| 10/10/2012 | EP2508613A2 Glycosylation of molecules | 
| 10/10/2012 | EP2508612A2 Glycosylation of molecules | 
| 10/10/2012 | EP2508603A1 System for increasing gene expression, and vector supporting said system | 
| 10/10/2012 | EP2508596A2 MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use | 
| 10/10/2012 | EP2507628A1 Improved methods and compositions for detecting and treating cea-expressing cancers | 
| 10/10/2012 | EP2507381A2 Multispecific antibodies, antibody analogs, compositions, and methods | 
| 10/10/2012 | EP2506871A1 ANTIBODY Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS | 
| 10/10/2012 | CN1304450B Novel insulin analogs with enhanced zinc binding | 
| 10/10/2012 | CN102725416A Novel antibodies and their uses in therapeutic and diagnostic methods | 
| 10/10/2012 | CN102719510A Amino acid fermentation bacteria utilization method | 
| 10/10/2012 | CN102719509A Casein phosphopeptide and preparation method thereof | 
| 10/10/2012 | CN102719508A Glycopegylated factor VII and factor VIIA | 
| 10/10/2012 | CN102719507A Method for preparing MHC (Major Histocompatibility Complex) II molecules by culturing in vitro and inducing lymphocytes and application thereof | 
| 10/10/2012 | CN102719506A Application of lactose to expression of hIGF-1 (Human Insulin-like Growth Factor-1) by high density fermentation of recombinant colon bacillus | 
| 10/10/2012 | CN102719505A Method for preparing vegetable protein small peptide by microoprganism fermentation | 
| 10/10/2012 | CN102719421A Marine bacteria cold-adapted protease and encoding gene and application thereof | 
| 10/10/2012 | CN102719408A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome | 
| 10/10/2012 | CN102718857A Denatured protein powder and brain protein hydrolyzate prepared from same | 
| 10/10/2012 | CN102718832A Marine organism collagen peptide | 
| 10/10/2012 | CN101880675B High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application | 
| 10/10/2012 | CN101857636B Anti-interferon-alpha antibodies | 
| 10/10/2012 | CN101845084B Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen | 
| 10/10/2012 | CN101817878B Monomer quick-acting insulin as well as preparing method and application thereof | 
| 10/10/2012 | CN101613395B Improved gene construction method and property testing of fast-acting insulin precursor | 
| 10/10/2012 | CN101444624B Medicine for cancer therapy | 
| 10/10/2012 | CN101434982B Method for preparing vegetable seed active peptide by microbial solid state fermentation | 
| 10/10/2012 | CN101163718B Reagents that bind ccx-ckr2 | 
| 10/10/2012 | CN101151276B Method of producing protein by using hamster IGF-1 | 
| 10/09/2012 | US8283518 Administration of transposon-based vectors to reproductive organs | 
| 10/09/2012 | US8283450 Human monoclonal antibody human CD134 (OX40) and methods of making and using same | 
| 10/09/2012 | US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof | 
| 10/09/2012 | US8283161 Tumour cell lines and uses thereof | 
| 10/09/2012 | US8283152 Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism | 
| 10/09/2012 | US8283149 Detergent composition comprising a polypeptide having lipase activity and polynucleotide encoding same | 
| 10/09/2012 | US8283144 Fermentive production of four carbon alcohols | 
| 10/09/2012 | US8283138 Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins | 
| 10/09/2012 | US8283137 Process for producing recombinant fibrinogen highly producing cell and highly producing cell | 
| 10/09/2012 | US8283136 Skin treatment compositions | 
| 10/09/2012 | US8283118 Isolated genomic polynucleotide fragments from chormosome 19 that encode human syntaxin binding protein 2 | 
| 10/09/2012 | US8282930 Molecular delivery vehicle | 
| 10/09/2012 | US8282926 CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5 | 
| 10/09/2012 | US8282924 Hybrid antibodies | 
| 10/09/2012 | US8282922 Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibody | 
| 10/09/2012 | US8282915 Transgenic algae for delivering antigens to an animal | 
| 10/09/2012 | CA2711685C Modified nodavirus rna for gene delivery | 
| 10/09/2012 | CA2536923C Extracellular matrix composite materials, and manufacture and use thereof | 
| 10/09/2012 | CA2476901C Anti-ccr5 antibody | 
| 10/09/2012 | CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses | 
| 10/09/2012 | CA2417415C Expression of biologically active polypeptides in duckweed | 
| 10/09/2012 | CA2408847C Cng3b: a novel cyclic nucleotide-gated cation channel | 
| 10/09/2012 | CA2358517C Method and composition for angiogenesis inhibition | 
| 10/04/2012 | WO2012135535A1 Method of identifying soluble proteins and soluble protein complexes | 
| 10/04/2012 | WO2012135500A1 Engineered thioredoxin-like fold proteins | 
| 10/04/2012 | WO2012135332A1 Modulators of plexin b2 activity | 
| 10/04/2012 | WO2012134262A2 A method for extracting protein from pectin rich plant material | 
| 10/04/2012 | WO2012133782A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity | 
| 10/04/2012 | WO2012133761A1 Modified glucose dehydrogenase | 
| 10/04/2012 | WO2012133572A1 Method for selecting plasma cells and plasmablasts, method for producing target antigen-specific antibody, and new monoclonal antibody | 
| 10/04/2012 | WO2012133349A1 Protein for affinity-separation matrix | 
| 10/04/2012 | WO2012133119A1 Method for producing ferritin | 
| 10/04/2012 | WO2012132067A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity | 
| 10/04/2012 | WO2012109285A3 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use | 
| 10/04/2012 | WO2012103114A3 Therapeutic chimeric ligand binding proteins and methods for their use | 
| 10/04/2012 | WO2012075422A3 Compositions and methods for treating amyloid plaque associated symptoms | 
| 10/04/2012 | US20120253026 Expanding the Eukaryotic Genetic Code | 
| 10/04/2012 | US20120253016 Antibody molecules that bind to il-6 receptor | 
| 10/04/2012 | US20120253009 Thrombopoietic compounds | 
| 10/04/2012 | US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof | 
| 10/04/2012 | US20120252876 Trans-acting rna switches | 
| 10/04/2012 | US20120252742 Human Single-Chain T Cell Receptors |